AKESF
Price
$12.10
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
10.61B
RGBP
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
1.13M
Interact to see
Advertisement

AKESF vs RGBP

Header iconAKESF vs RGBP Comparison
Open Charts AKESF vs RGBPBanner chart's image
AKESO
Price$12.10
Change-$0.00 (-0.00%)
Volume$1.18K
Capitalization10.61B
Regen Biopharma
Price$0.05
Change-$0.00 (-0.00%)
Volume$5.23K
Capitalization1.13M
AKESF vs RGBP Comparison Chart in %
Loading...
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKESF vs. RGBP commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Hold and RGBP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (AKESF: $12.10 vs. RGBP: $0.05)
Brand notoriety: AKESF and RGBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 34% vs. RGBP: 31%
Market capitalization -- AKESF: $10.61B vs. RGBP: $1.13M
AKESF [@Biotechnology] is valued at $10.61B. RGBP’s [@Biotechnology] market capitalization is $1.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileRGBP’s FA Score has 1 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • RGBP’s FA Score: 1 green, 4 red.
According to our system of comparison, AKESF is a better buy in the long-term than RGBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKESF’s TA Score shows that 2 TA indicator(s) are bullish while RGBP’s TA Score has 1 bullish TA indicator(s).

  • AKESF’s TA Score: 2 bullish, 5 bearish.
  • RGBP’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, AKESF is a better buy in the short-term than RGBP.

Price Growth

AKESF (@Biotechnology) experienced а -2.42% price change this week, while RGBP (@Biotechnology) price change was +11.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

RGBP is expected to report earnings on May 16, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKESF($10.6B) has a higher market cap than RGBP($1.13M). AKESF YTD gains are higher at: 72.857 vs. RGBP (-25.164).
AKESFRGBPAKESF / RGBP
Capitalization10.6B1.13M940,550%
EBITDAN/A-804.74K-
Gain YTD72.857-25.164-290%
P/E Ratio25.37N/A-
RevenueN/A237K-
Total CashN/A1.76K-
Total DebtN/A968K-
FUNDAMENTALS RATINGS
RGBP: Fundamental Ratings
RGBP
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKESFRGBP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LFAR151.160.83
+0.55%
LifeX 2057 Longevity Income ETF
SCHC42.680.23
+0.54%
Schwab International Small-Cap Eq ETF™
FDT68.910.31
+0.45%
First Trust Dev Mkts Ex-US AlphaDEX® ETF
BBSB98.81-0.08
-0.08%
JPMorgan BetaBuilders U.S. TrsBd1-3YrETF
JHMB21.84-0.02
-0.09%
JHancock Mortgage Backed Sec ETF

AKESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKESF has been loosely correlated with INBX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AKESF jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
N/A
INBX - AKESF
45%
Loosely correlated
+7.02%
SMMT - AKESF
27%
Poorly correlated
+6.89%
NUVL - AKESF
25%
Poorly correlated
+3.19%
BNTX - AKESF
23%
Poorly correlated
+0.70%
CPMV - AKESF
22%
Poorly correlated
N/A
More

RGBP and

Correlation & Price change

A.I.dvisor tells us that RGBP and SABS have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGBP and SABS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGBP
1D Price
Change %
RGBP100%
-2.03%
SABS - RGBP
23%
Poorly correlated
N/A
ASPHF - RGBP
8%
Poorly correlated
N/A
SHJBF - RGBP
8%
Poorly correlated
N/A
ROIV - RGBP
5%
Poorly correlated
+0.27%
AKESF - RGBP
4%
Poorly correlated
N/A
More